Hospira Recalls Dobutamine Injection Vials Due to Glass Particulate Matter
Hospira Inc. is recalling 123,900 vials of Dobutamine Injection due to the presence of glass particulate matter and a discolored solution.
- Product
- DOBUTAMINE — DOBUTAMINE (DOBUTAMINE)
- Category
- Drug
- Distribution
- Distributed nationwide